The aromatic α,β-unsaturated carbonyl compounds are known to possess biological and pharmacological activities, such as antioxidative, antibacterial, and antiviral effects. We tested the affinities of six new compounds to bind to the catalytic site of the dihydrofolate reductase enzyme. The binding modes of 1-aryl-(3-substitutedquinolyl)-prop-2-en-1-one analogues to the active site of the dihydrofolate reductase are investigated with ligand docking calculations. Docking simulations indicated that these compounds have the same binding modes for dihydrofolate reductase as methotrexate.
INTRODUCTION
The important step in the treatment of cancer is to find the drug that can inhibit the catalytic reaction responsible of this cellular anomaly. Different treatments are based on the inhibition of some enzymes. Dihydrofolate reductase (DHFR, EC 1.5.1.3) was the first enzyme targeted by chemotherapy. DHFR plays an essential role in the process of DNA replication, making it responsible of the growth and proliferation of cells that are characteristic of cancer. 1) This enzyme was a target of several cytostatic and anti-bacterial drugs. Therefore, its inhibition is a key element in the treatment of many diseases. 2) In this work, we aim at the determination of electronic properties, drug-likeness, the binding orientation, and the free energy of binding of six new compounds on the active site of DHFR and we compare with those of the methotrexate (MTX). The latter is an antimetabolite and antifolate drug used in the treatment of cancer. 3) It acts specifically during DNA and RNA synthesis. Due to its similar structure to that of folic acid, MTX is a competitive inhibitor of DHFR.
The new compounds, 1-phenyl-3-[3-(2-chloro-7-methoxyquinolyl)]-2-propen-1-one and its derivatives are called: ary, ary1, ary2, ary3, ary4, ary5 (see Fig. 1 ). They have been demonstrated to have anticancer biological activity. 4) Their synthesis was elaborated by subjecting a series of anilides to Vilsmeier reagent. They have been obtained by filtration on pouring the reaction mixture into ice water. 4) The structure of ary and its derivatives were confirmed by spectroscopic analysis [infrared spectroscopy (IR), nuclear magnetic resonance (NMR), and mass spectrometry (MS)] 4) and show similarities to the structure of natural anticancer compounds extracted from plants used in Chinese medicine. 5) 
MATERIALS AND METHODS
The G-point structural optimization of ligands was performed in the framework of density functional theory DFT as implemented in the Quantum-ESPRESSO package 6) within the generalized gradient approximation GGA using ultrsoft pseudopotentials (C:2s 2 2p 2 , Cl:3s 2 3p 5 , H:1s 1 , N:2s 2 2p 3 , and O:2s 2 2p 4 ) and a kinetic energy cutoff of 70 Ry. HOMO/LUMO energies and functions have been evaluated using Austin Model 1 (AM1) method. 7) The docking calculations were performed using ArgusLab 4.0.1 (www.ArgusLab.com, Planaria Soft- The experimental structure of DHFR protein complexed with methotrexate inhibitor is taken from the Protein Data Bank (PDB: PDB code 4dfr), 8) with a resolution of 1.70 Å. The dihydrofolate reductase-methotrexate complex was determined by Bolin et al. 9) The binding pocket of the DHFR was defined with all amino acid residues and water molecules within 3.5 Å from experimental structure of methotrexate.
During docking simulations, the protein is considered as rigid. The flexibility of the ligand is due to different conformations resulting from translations/rotations around acyclic single bonds of the ligand structure and the multiple conformers of ring structures. Bond lengths and angles are kept constant as given in the input structure.
Docking simulations produced 150 possible docked conformations for each ligand. These poses were sorted with Ascore scoring function. 10) Among these solutions, those with the best Ascore value (lowest energy) were chosen as the optimal conformational pose.
To evaluate drug likeness and oral activity of our six compounds, we have checked if they obey to the five rules of Lipinski 11, 12) stating that: not more than 5 hydrogen bond donors (OH and NH groups), not more than 10 hydrogen bond acceptors (notably N and O), not more than 15 rotatable bonds (rotb), a molecular weight (M.W.) under 500 g/mol, and a partition coefficient log P (mi.LogP) less than 5.
RESULT AND DISCUSSION
The chalcone compounds (Fig. 1 ) possess a plane geometry structure because of pi conjugated electrons of double bonds and aromatic fragments. They share the same basic skeleton except for the difference in 7, 8, 3 and 4 substitutes. They have two rigid parts which are quinolyl and phenyl rings. During the complexation, the flexibility of these molecules is assigned to the acyclic bounds between the two ring systems. The stability of these ligands was evaluated by an energy levels analysis. We have calculated for each compound the orbital energy of both HOMO and LUMO, and energy gap. Molecules with substituted phenyl group have close energy gap values (0.2807, 0.2810, 0.2842 a.u.) for ary1, ary2, and ary5, respectively). Adding an extra methoxy to the phenyl ring narrows the energy gap (0.2770 a.u.). Molecules with non-substituted phenyl ring, ary and ary4 have energy gap of 0.2807 and 0.2698 a.u., respectively. The favourable binding orientations of all these compounds were focused in the active site. According to binding free energy calculations, ary and ary4 molecules form the best complexes with DHFR (see Table 1 ). Therefore, the least stable complexe is formed with ary3, having the most substituted phenyl group.
The structure of 4dfr was used to prepare the target site for docking calculations. 150 docked conformations were created for each compound. These conformations were ranked on the basis of Ascore scoring function that estimates the binding free energy of DHFR-ligand complex. The binding free energies of the best conformations of each complex were computed and are listed in Table 1 . The studied ligands have good binding affinity toward DHFR enzyme. All molecules were attached to the receptor site of DHFR with hydrophobic interactions forces which stabilize the compounds in this pocket. As it is shown on Fig. 2 , there is one hydrogen bond between the oxygen of the methoxy group at C8 of ary4 and Arg52 (bond length is 2.52 Å). This ligand produced the more stable complex with ΔG equal to −11.70 kcal/mol. The superposition (superimposition) of ary4 (green) and methotrexate (blue) revealed that the quinolyl ring overlapped with acyclic part of the methotrexate. We noted that HOMO is located on these two parts of the molecule (Fig. 3) . Thus, quinolyl ring system and chalcone function have a crucial role in the binding mode of this molecule to the active site of DHFR.
Docking results demonstrated that ary4 and ary with no substitutions at phenyl ring have formed the two best complexes with ΔG equal to −11.70 and 11.18 kcal/mol, respectively. According to the results listed in Table 2 , all molecules fulfil Lipinski rules except for ary5 that violates the last condition of partition coefficient. These ligands are accepted to be orally bioavailable. All the molecules have a high coefficient partition logarithm of partition co- In conclusion, in this work, electronic properties analysis together with docking simulations were carried out to explore the binding mode of six new aromatic α,β unsaturated carbonyl compounds to DHFR catalytic site. We confirmed the potential of the studied molecules as candidate inhibitors of DHFR.
The phenyl group substitution lowers the efficiency of the molecule in the complexation with DHFR. The substitution of hydrogen atoms of phenyl group alters the topology of HOMO and LUMO and reduces the compatibility of the molecule with MTX as a competitive inhibitor.
Most DHFR-ligand interactions are hydrophobic. They are responsible of the stabilisation of these molecules in the DHFR cavity. The hydrophobic character of the molecules is confirmed by a high partition coefficient.
